Inventor · disambiguated record
Yongqi Deng
Also filed as: DENG YONGQI
23 granted patents·7 pending applications·63 citations·filing 2003–2022
92Inventor score
Files withMERCK SHARP & DOHME7SCHERING CORP4MERCK SHARP & DOHME LLC3SHIPPS JR GERALD W3COOPER ALAN B2
Top patents by PatentIndex Score
30 records- 0193US7807672B2Compounds that are ERK inhibitorsSCHERING CORP·Filed 2007·Granted Oct 5, 2010·16 cites·23 claims
- 0288US9242981B2Fused pyrazole derivatives as novel ERK inhibitorsSHIPPS JR GERALD W·Filed 2011·Granted Jan 26, 2016·9 cites·2 claims
- 0386US8546404B2Compounds that are ERK inhibitorsCOOPER ALAN B·Filed 2007·Granted Oct 1, 2013·9 cites·76 claims
- 0485US9351965B2Indazole derivatives useful as ERK inhibitorsSHIPPS JR GERALD W·Filed 2011·Granted May 31, 2016·5 cites·2 claims
- 0581US10995085B2Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2020·Granted May 4, 2021·1 cites·12 claims
- 0675US8591943B2Pyrazolo[1,5-a]pyrimidine derivatives as mTOR inhibitorsDENG YONGQI·Filed 2010·Granted Nov 26, 2013·6 cites·2 claims
- 0775US7196111B2Pyrazolo[1,5a]pyrimidine compounds as antiviral agentsSCHERING CORP·Filed 2003·Granted Mar 27, 2007·8 cites·2 claims
- 0873US9730940B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2013·Granted Aug 15, 2017·3 cites·9 claims
- 0973US8716483B2Compounds that are ERK inhibitorsCOOPER ALAN B·Filed 2009·Granted May 6, 2014·2 cites·12 claims
- 1069US7446195B2High affinity thiophene-based and furan-based kinase ligandsSCHERING CORP·Filed 2006·Granted Nov 4, 2008·1 cites·10 claims
- 1166US9957264B2Geminally substituted cyanoethylpyrazolo pyridones as Janus kinase inhibitorsMERCK SHARP & DOHME·Filed 2014·Granted May 1, 2018·1 cites·9 claims
- 1266US8999966B2Compounds that are ERK inhibitorsBOGA SOBHANA BABU·Filed 2011·Granted Apr 7, 2015·1 cites·6 claims
- 1363US10647705B2Substituted biaryl compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2018·Granted May 12, 2020·0 cites·16 claims
- 1461US2024294511A1Solid form of indole compound, preparation method therefor and use thereofKEYTHERA SUZHOU BIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 1559US8609675B2Fused Tricyclic Compounds as novel mTOR inhibitorsCHENG CLIFF C·Filed 2010·Granted Dec 17, 2013·1 cites·14 claims
- 1653US12157727B2Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME LLC·Filed 2020·Granted Dec 3, 2024·0 cites·20 claims
- 1753US2022396577A1Novel substituted 1,3-8-triazaspiro[4,5] decane-2,4-dione compounds as indoleamine 2,3-dioxygenase (ido) and/or tryptophan 2,3-dioxygenase (tdo) inhibitorsMERCK SHARP & DOHME LLC·Filed 2020·Application pending·0 cites
- 1852US12283601B2Method for manufacturing TFT substrate and TFT substrate thereofHUIZHOU CHINA STAR OPTOELECTRONICS DISPLAY CO LTD·Filed 2021·Granted Apr 22, 2025·0 cites·19 claims
- 1950US12275729B2Substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME LLC·Filed 2018·Granted Apr 15, 2025·0 cites·5 claims
- 2050US2025051324A1Parp inhibitor, pharmaceutical composition comprising same, and use thereofKEYTHERA SUZHOU BIO PHARMACEUTICALS CO LTD·Filed 2022·Application pending·0 cites
- 2148US7511063B2High affinity quinoline-based kinase ligandsSCHERING CORP·Filed 2006·Granted Mar 31, 2009·0 cites·51 claims
- 2247US2011038876A1Heterocyclic compounds and use thereof as erk inhibitorsSUN ROBERT·Filed 2008·Application pending·0 cites
- 2343US12240812B2Compound for inhibiting PGE2/EP4 signaling transduction inhibiting, preparation method therefor, and medical uses thereofKEYTHERA SUZHOU PHARMACEUTICALS CO LTD·Filed 2020·Granted Mar 4, 2025·0 cites·12 claims
- 2442US10988487B2Substituted n′-hydroxycarbamimidoyl-1,2,5-oxadiazole compounds as indoleamine 2,3-dioxygenase (IDO) inhibitorsMERCK SHARP & DOHME·Filed 2017·Granted Apr 27, 2021·0 cites·20 claims
- 2541US9938281B2Purine inhibitors of human phosphatidylinositol 3-kinase deltaMERCK SHARP & DOHME·Filed 2013·Granted Apr 10, 2018·0 cites·18 claims
- 2641US8999957B2Heterocyclic compounds as ERK inhibitorsDENG YONGQI·Filed 2011·Granted Apr 7, 2015·0 cites·15 claims
- 2741US2007191604A1Novel compounds that are ERK inhibitorsCOOPER ALAN·Filed 2006·Application pending·0 cites
- 2840US2022017520A1Macrocyclic compound as cdk inhibitor, preparation method therefor, and use thereof in medicineKEYTHERA SUZHOU PHARMACEUTICALS CO LTD·Filed 2019·Application pending·0 cites
- 2939US10538497B2Compounds as indoleamine 2,3-dioxygenase inhibitorsMERCK SHARP & DOHME·Filed 2016·Granted Jan 21, 2020·0 cites·19 claims
- 3032US2012220567A1Benzo-fused oxazepine compounds as stearoyl-coenzyme a delta-9 desaturase inhibitorsSHIPPS JR GERALD W·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Yongqi Deng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →